Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 10163.65 | 2629 / 2642 | 100% | 61.43 | 702 / 705 |
prostate | 97% | 6539.19 | 238 / 245 | 95% | 32.00 | 479 / 502 |
lung | 99% | 5885.31 | 571 / 578 | 91% | 26.38 | 1047 / 1155 |
ovary | 91% | 2971.22 | 164 / 180 | 95% | 32.49 | 409 / 430 |
thymus | 96% | 3614.02 | 625 / 653 | 90% | 21.85 | 542 / 605 |
kidney | 96% | 4407.47 | 85 / 89 | 86% | 26.84 | 776 / 901 |
intestine | 82% | 4268.05 | 794 / 966 | 93% | 25.42 | 489 / 527 |
liver | 100% | 9257.76 | 226 / 226 | 69% | 11.64 | 282 / 406 |
bladder | 86% | 5760.10 | 18 / 21 | 82% | 24.80 | 414 / 504 |
breast | 61% | 2280.15 | 282 / 459 | 88% | 21.56 | 987 / 1118 |
pancreas | 50% | 1073.74 | 164 / 328 | 93% | 22.41 | 165 / 178 |
stomach | 56% | 1214.31 | 202 / 359 | 86% | 23.14 | 246 / 286 |
esophagus | 53% | 1315.13 | 767 / 1445 | 85% | 18.85 | 156 / 183 |
uterus | 55% | 1573.73 | 93 / 170 | 58% | 11.47 | 267 / 459 |
spleen | 100% | 12231.65 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.43 | 1 / 1 |
peripheral blood | 100% | 41619.91 | 928 / 929 | 0% | 0 | 0 / 0 |
skin | 43% | 1063.35 | 785 / 1809 | 46% | 10.30 | 217 / 472 |
lymph node | 0% | 0 | 0 / 0 | 86% | 30.03 | 25 / 29 |
blood vessel | 82% | 2795.33 | 1094 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 15.95 | 36 / 45 |
adrenal gland | 23% | 465.73 | 60 / 258 | 47% | 11.66 | 108 / 230 |
adipose | 31% | 825.44 | 371 / 1204 | 0% | 0 | 0 / 0 |
heart | 10% | 204.11 | 90 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 1.06 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045053 | Biological process | protein retention in Golgi apparatus |
GO_1900168 | Biological process | positive regulation of glial cell-derived neurotrophic factor production |
GO_1904179 | Biological process | positive regulation of adipose tissue development |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0010897 | Biological process | negative regulation of triglyceride catabolic process |
GO_0006622 | Biological process | protein targeting to lysosome |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_1902955 | Biological process | positive regulation of early endosome to recycling endosome transport |
GO_1902430 | Biological process | negative regulation of amyloid-beta formation |
GO_0006892 | Biological process | post-Golgi vesicle-mediated transport |
GO_0002024 | Biological process | diet induced thermogenesis |
GO_0038020 | Biological process | insulin receptor recycling |
GO_0031333 | Biological process | negative regulation of protein-containing complex assembly |
GO_1902953 | Biological process | positive regulation of ER to Golgi vesicle-mediated transport |
GO_0099638 | Biological process | endosome to plasma membrane protein transport |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_1902966 | Biological process | positive regulation of protein localization to early endosome |
GO_1902997 | Biological process | negative regulation of neurofibrillary tangle assembly |
GO_0006605 | Biological process | protein targeting |
GO_1990845 | Biological process | adaptive thermogenesis |
GO_0014910 | Biological process | regulation of smooth muscle cell migration |
GO_0034067 | Biological process | protein localization to Golgi apparatus |
GO_0070863 | Biological process | positive regulation of protein exit from endoplasmic reticulum |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_1902992 | Biological process | negative regulation of amyloid precursor protein catabolic process |
GO_0046628 | Biological process | positive regulation of insulin receptor signaling pathway |
GO_2001137 | Biological process | positive regulation of endocytic recycling |
GO_0016477 | Biological process | cell migration |
GO_0050768 | Biological process | negative regulation of neurogenesis |
GO_0051604 | Biological process | protein maturation |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0005641 | Cellular component | nuclear envelope lumen |
GO_0031985 | Cellular component | Golgi cisterna |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0005769 | Cellular component | early endosome |
GO_0031901 | Cellular component | early endosome membrane |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0009986 | Cellular component | cell surface |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005771 | Cellular component | multivesicular body |
GO_0010008 | Cellular component | endosome membrane |
GO_0030658 | Cellular component | transport vesicle membrane |
GO_0005768 | Cellular component | endosome |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0097356 | Cellular component | perinucleolar compartment |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0019828 | Molecular function | aspartic-type endopeptidase inhibitor activity |
GO_0042923 | Molecular function | neuropeptide binding |
GO_0005041 | Molecular function | low-density lipoprotein particle receptor activity |
GO_0030169 | Molecular function | low-density lipoprotein particle binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SORL1 |
Protein name | Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Alternative protein SORL1 Sortilin related receptor 1 |
Synonyms | C11orf32 |
Description | FUNCTION: Sorting receptor that directs several proteins to their correct location within the cell (Probable). Along with AP-1 complex, involved Golgi apparatus - endosome sorting . Sorting receptor for APP, regulating its intracellular trafficking and processing into amyloidogenic-beta peptides. Retains APP in the trans-Golgi network, hence preventing its transit through late endosomes where amyloid beta peptides Abeta40 and Abeta42 are generated . May also sort newly produced amyloid-beta peptides to lysosomes for catabolism . Does not affect APP trafficking from the endoplasmic reticulum to Golgi compartments . Sorting receptor for the BDNF receptor NTRK2/TRKB that facilitates NTRK2 trafficking between synaptic plasma membranes, postsynaptic densities and cell soma, hence positively regulates BDNF signaling by controlling the intracellular location of its receptor . Sorting receptor for GDNF that promotes GDNF regulated, but not constitutive secretion . Sorting receptor for the GDNF-GFRA1 complex, directing it from the cell surface to endosomes. GDNF is then targeted to lysosomes and degraded, while its receptor GFRA1 recycles back to the cell membrane, resulting in a GDNF clearance pathway. The SORL1-GFRA1 complex further targets RET for endocytosis, but not for degradation, affecting GDNF-induced neurotrophic activities . Sorting receptor for ERBB2/HER2. Regulates ERBB2 subcellular distribution by promoting its recycling after internalization from endosomes back to the plasma membrane, hence stimulating phosphoinositide 3-kinase (PI3K)-dependent ERBB2 signaling. In ERBB2-dependent cancer cells, promotes cell proliferation . Sorting receptor for lipoprotein lipase LPL. Promotes LPL localization to endosomes and later to the lysosomes, leading to degradation of newly synthesized LPL . Potential sorting receptor for APOA5, inducing APOA5 internalization to early endosomes, then to late endosomes, wherefrom a portion is sent to lysosomes and degradation, another portion is sorted to the trans-Golgi network . Sorting receptor for the insulin receptor INSR. Promotes recycling of internalized INSR via the Golgi apparatus back to the cell surface, thereby preventing lysosomal INSR catabolism, increasing INSR cell surface expression and strengthening insulin signal reception in adipose tissue. Does not affect INSR internalization . Plays a role in renal ion homeostasis, controlling the phospho-regulation of SLC12A1/NKCC2 by STK39/SPAK kinase and PPP3CB/calcineurin A beta phosphatase, possibly through intracellular sorting of STK39 and PPP3CB (By similarity). Stimulates, via the N-terminal ectodomain, the proliferation and migration of smooth muscle cells, possibly by increasing cell surface expression of the urokinase receptor uPAR/PLAUR. This may promote extracellular matrix proteolysis and hence facilitate cell migration . By acting on the migration of intimal smooth muscle cells, may accelerate intimal thickening following vascular injury . Promotes adhesion of monocytes . Stimulates proliferation and migration of monocytes/macrophages (By similarity). Through its action on intimal smooth muscle cells and macrophages, may accelerate intimal thickening and macrophage foam cell formation in the process of atherosclerosis (By similarity). Regulates hypoxia-enhanced adhesion of hematopoietic stem and progenitor cells to the bone marrow stromal cells via a PLAUR-mediated pathway. This function is mediated by the N-terminal ectodomain . Metabolic regulator, which functions to maintain the adequate balance between lipid storage and oxidation in response to changing environmental conditions, such as temperature and diet. The N-terminal ectodomain negatively regulates adipose tissue energy expenditure, acting through the inhibition the BMP/Smad pathway (By similarity). May regulate signaling by the heterodimeric neurotrophic cytokine CLCF1-CRLF1 bound to the CNTFR receptor by promoting the endocytosis of the tripartite complex CLCF1-CRLF1-CNTFR and lysosomal degradation . May regulate IL6 signaling, decreasing cis signaling, possibly by interfering with IL6-binding to membrane-bound IL6R, while up-regulating trans signaling via soluble IL6R . . |
Accessions | ENST00000525532.5 Q92673 L8EA23 ENST00000527934.1 E9PP43 ENST00000534286.5 E9PKB0 E9PS32 E9PPB3 ENST00000260197.12 ENST00000532694.5 |